Mehmet Abdullah Alagöz1, Zeynep Özdemir1, Mehtap Uysal2, Simone Carradori3, Marialucia Gallorini3, Alessia Ricci3, Susi Zara3, Bijo Mathew4. 1. İnönü University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 44280 Malatya, Turkey. 2. Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 06010 Ankara, Turkey. 3. Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Italy. 4. Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682 041, India.
Abstract
Novel twenty-three 3(2H)-pyridazinone derivatives were designed and synthesized based on the chemical requirements related to the anti-proliferative effects previously demonstrated within this scaffold. The introduction of a piperazinyl linker between the pyridazinone nucleus and the additional (un)substituted phenyl group led to some compounds endowed with a limited cytotoxicity against human gingival fibroblasts (HGFs) and good anti-proliferative effects against gastric adenocarcinoma cells (AGS) as evaluated by MTT and LDH assays, using doxorubicin as a positive control. Successive analyses revealed that the two most promising representative compounds (12 and 22) could exert their effects by inducing oxidative stress as demonstrated by the hydrogen peroxide release and the morphological changes (cell blebbing) revealed by light microscopy analysis after the haematoxylin-eosin staining. Moreover, to further assess the apoptotic process induced by compounds 12 and 22, Bax expression was measured by flow cytometry. These findings enlarged our knowledge of the structural requirements in this scaffold to display valuable biological effects against cancerous cell lines.
Novel twenty-three 3(2H)-pyridazinone derivatives were designed and synthesized based on the chemical requirements related to the anti-proliferative effects previously demonstrated within this scaffold. The introduction of a n class="Chemical">piperazinyl linker between the pyridazinone nucleus and the additional (un)substituted phenyl group led to some compounds endowed with a limited cytotoxicity against human gingival fibroblasts (HGFs) and good anti-proliferative effects against gastric adenocarcinoma cells (AGS) as evaluated by MTT and LDH assays, using doxorubicin as a positive control. Successive analyses revealed that the two most promising representative compounds (12 and 22) could exert their effects by inducing oxidative stress as demonstrated by the hydrogen peroxide release and the morphological changes (cell blebbing) revealed by light microscopy analysis after the haematoxylin-eosin staining. Moreover, to further assess the apoptotic process induced by compounds 12 and 22, Bax expression was measured by flow cytometry. These findings enlarged our knowledge of the structural requirements in this scaffold to display valuable biological effects against cancerous cell lines.
Authors: Andrey P Jacomini; Michael J V Silva; Raí G M Silva; Davana S Gonçalves; Hélito Volpato; Ernani A Basso; Fávero R Paula; Celso V Nakamura; Maria Helena Sarragiotto; Fernanda A Rosa Journal: Eur J Med Chem Date: 2016-08-23 Impact factor: 6.514
Authors: Wan M Khairul; Fatimah Hashim; Mas Mohammed; Nurul S M N Shah; Syed A T T Johari; Rafizah Rahamathullah; Adibah I Daud; Nyuk L Ma Journal: Anticancer Agents Med Chem Date: 2021 Impact factor: 2.505
Authors: Mehmet Abdullah Alagöz; Jong Min Oh; Yaren Nur Zenni; Zeynep Özdemir; Mohamed A Abdelgawad; Ibrahim A Naguib; Mohammed M Ghoneim; Nicola Gambacorta; Orazio Nicolotti; Hoon Kim; Bijo Mathew Journal: Molecules Date: 2022-06-13 Impact factor: 4.927